| Cat. No. |
Product |
Quantity/Size |
Price |
Data |
|
| DHD00502B |
Research Grade Anti-Human OSM/Oncostatin-M (GSK315234) |
1.0 mg |
$1,715.00
|
 |
BUY
|
| DHK13704B |
Research Grade Anti-Human SIGLEC15/CD33L3 (DS1501) mAb |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHK13704A |
Research Grade Anti-Human SIGLEC15/CD33L3 (DS1501) mAb |
100 µg |
$420.00
|
|
BUY
|
| DHF64001A |
Research Grade Anti-Human SIRPα / γ Antibody (Kwar23) |
100 µg |
$420.00
|
|
BUY
|
| DHF64001B |
Research Grade Anti-Human SIRPα / γ Antibody (Kwar23) |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHE22008B |
Research Grade Anti-Human SNCA/Alpha-synuclein (Lu AF82422) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHE22008A |
Research Grade Anti-Human SNCA/Alpha-synuclein (Lu AF82422) |
100 ug |
$475.00
|
|
BUY
|
| DHH72415B |
Research Grade Anti-Human TIGIT (BMS 986207) |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHH72415A |
Research Grade Anti-Human TIGIT (BMS 986207) |
100 ug |
$420.00
|
|
BUY
|
| DHH72416A |
Research Grade Anti-Human TIGIT (COM902) |
100 ug |
$420.00
|
|
BUY
|
| DHH72416B |
Research Grade Anti-Human TIGIT (COM902) |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHK23201B |
Research Grade Anti-Human TNFRSF25 (PTX-35) mAb |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHK23201A |
Research Grade Anti-Human TNFRSF25 (PTX-35) mAb |
100 µg |
$475.00
|
|
BUY
|
| DHB54003A |
Research Grade Anti-Human TNFSF15/TL1A (PRA023) |
100 µg |
$405.00
|
|
BUY
|
| DHB54003B |
Research Grade Anti-Human TNFSF15/TL1A (PRA023) |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHG62603A |
Research Grade Anti-Human TPBG/5T4 (ASN004) |
100 ug |
$475.00
|
|
BUY
|
| DHG62603B |
Research Grade Anti-Human TPBG/5T4 (ASN004) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DVV03807B |
Research Grade Anti-Influenza A virus HA/Hemagglutinin Broad-Neutralizing Antibody (CR9114) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DVV03807A |
Research Grade Anti-Influenza A virus HA/Hemagglutinin Broad-Neutralizing Antibody (CR9114) |
100 ug |
$475.00
|
|
BUY
|
| DVV00332B |
Research Grade Anti-SARS-CoV-2 Spike Protein/RBD Broad-Neutralizing Antibody (002-S21F2) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DVV00332A |
Research Grade Anti-SARS-CoV-2 Spike Protein/RBD Broad-Neutralizing Antibody (002-S21F2) |
100 µg |
$475.00
|
|
BUY
|
| DVV00317A |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb |
100 µg |
$420.00
|
|
BUY
|
| DVV00317B |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00317B-BT |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb, Biotin labeled |
1.0 mg |
$2,310.00
|
|
BUY
|
| DVV00317X-BT |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb, Biotin labeled |
0.5 mg |
$1,485.00
|
|
BUY
|
| DHD47902A |
Research Grade Aprutumab |
100 ug |
$380.00
|
|
BUY
|
| DHD47902B |
Research Grade Aprutumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD03301A |
Research Grade Aselizumab |
100 ug |
$380.00
|
|
BUY
|
| DHD03301B |
Research Grade Aselizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHF92101B |
Research Grade Atorolimumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHF92101A |
Research Grade Atorolimumab |
100 ug |
$380.00
|
|
BUY
|
| DHD47201B |
Research Grade Avdoralimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD47201A |
Research Grade Avdoralimab |
100 ug |
$380.00
|
|
BUY
|
| DHC25203A |
Research Grade Axatilimab |
100 ug |
$380.00
|
|
BUY
|
| DHC25203B |
Research Grade Axatilimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ64002A |
Research Grade Azintuxizumab |
100 ug |
$380.00
|
|
BUY
|
| DHJ64002B |
Research Grade Azintuxizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02203A |
Research Grade Balstilimab |
100 ug |
$380.00
|
|
BUY
|
| DHH02203B |
Research Grade Balstilimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD47901A |
Research Grade Bemarituzumab |
100 ug |
$380.00
|
|
BUY
|
| DHD47901B |
Research Grade Bemarituzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC16001B |
Research Grade Bersanlimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC16001A |
Research Grade Bersanlimab |
100 ug |
$380.00
|
|
BUY
|
| DHD14801A |
Research Grade Bivatuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHD14801B |
Research Grade Bivatuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD68902A |
Research Grade Bleselumab |
100 ug |
$380.00
|
|
BUY
|
| DHD68902B |
Research Grade Bleselumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02210A |
Research Grade Budigalimab |
100 ug |
$380.00
|
|
BUY
|
| DHH02210B |
Research Grade Budigalimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC25201B |
Research Grade Cabiralizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC25201A |
Research Grade Cabiralizumab |
100 ug |
$380.00
|
|
BUY
|
| DHH02211A |
Research Grade Camrelizumab |
100 ug |
$380.00
|
|
BUY
|
| DHH02211B |
Research Grade Camrelizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD14203A |
Research Grade Cantuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHD14203B |
Research Grade Cantuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC21002A |
Research Grade Cergutuzumab |
100 ug |
$420.00
|
|
BUY
|
| DHC21002B |
Research Grade Cergutuzumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHH02204A |
Research Grade Cetrelimab |
100 ug |
$380.00
|
|
BUY
|
| DHH02204B |
Research Grade Cetrelimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC21003A |
Research Grade Cibisatamab |
100 ug |
$560.00
|
|
BUY
|
| DHC21003B |
Research Grade Cibisatamab |
1.0 mg |
$2,030.00
|
|
BUY
|
| DHD17401B |
Research Grade Citatuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD17401A |
Research Grade Citatuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHC29904B |
Research Grade Cixutumumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC29904A |
Research Grade Cixutumumab |
100 ug |
$380.00
|
|
BUY
|
| DHD14205A |
Research Grade Clivatuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHD14205B |
Research Grade Clivatuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHA29103A |
Research Grade Conatumumab |
100 ug |
$380.00
|
|
BUY
|
| DHA29103B |
Research Grade Conatumumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ70106B |
Research Grade Cosibelimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ70106A |
Research Grade Cosibelimab |
100 ug |
$380.00
|
|
BUY
|
| DHE43204A |
Research Grade Cudarolimab |
100 ug |
$380.00
|
|
BUY
|
| DHE43204B |
Research Grade Cudarolimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHE01901A |
Research Grade Cusatuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHE01901B |
Research Grade Cusatuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD68908A |
Research Grade Dacetuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHD68908B |
Research Grade Dacetuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC09603B |
Research Grade Disitamab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC09603A |
Research Grade Disitamab |
100 ug |
$380.00
|
|
BUY
|
| DHA29104A |
Research Grade Drozitumab |
100 ug |
$430.00
|
|
BUY
|
| DHA29104B |
Research Grade Drozitumab |
1.0 mg |
$1,560.00
|
|
BUY
|
| DHA29113A |
Research Grade Eftozanermin Alfa |
100 ug |
$540.00
|
|
BUY
|
| DHA29113B |
Research Grade Eftozanermin Alfa |
1.0 mg |
$1,970.00
|
|
BUY
|
| DHC25202A |
Research Grade Emactuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHC25202B |
Research Grade Emactuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ62201A |
Research Grade Enavatuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHJ62201B |
Research Grade Enavatuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD30404B |
Research Grade Encelimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHD30404A |
Research Grade Encelimab |
100 ug |
$420.00
|
|
BUY
|
| DHC90713A |
Research Grade Epcoritamab |
100 ug |
$560.00
|
|
BUY
|
| DHC90713B |
Research Grade Epcoritamab |
1.0 mg |
$2,030.00
|
|
BUY
|
| DHD38503A |
Research Grade Epratuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHD38503B |
Research Grade Epratuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DVV00306A |
Research Grade Etesevimab |
100 ug |
$475.00
|
|
BUY
|
| DVV00306B |
Research Grade Etesevimab |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHC98803B |
Research Grade Etrolizumab |
1.0 mg |
$2,030.00
|
|
BUY
|
| DHC98803A |
Research Grade Etrolizumab |
100 ug |
$560.00
|
|
BUY
|
| DHH02220A |
Research Grade Ezabenlimab |
100 ug |
$380.00
|
|
BUY
|
| DHH02220B |
Research Grade Ezabenlimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ92102A |
Research Grade Feladilimab |
100 ug |
$380.00
|
|
BUY
|
